One of the most dreaded feelings for an investor is when the stock they just bought is overvalued, or they missed out on an undervalued opportunity by not acting fast enough.

But what if you had the insights to effectively evaluate a company like Bruker Corporation before investing? Investing requires a certain perspective to avoid being overly confident in a company or worried about cyclical changes. A smart way to take the guesswork out of knowing when to buy or sell Bruker Corporation’s stock is to have the right tools and resources as well as a clear monitoring process.

In this article, we go over a few key elements for understanding Bruker Corporation’s stock price such as:

• Current stock price and volume
• Stock price history
• Upgrades and downgrades from analysts
• Stock price momentum as measured by its relative strength

About Bruker Corporation (BRKR)

Before we jump into Bruker Corporation’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. The Company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy & Supercon Technologies (BEST). The BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. The BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. The BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments, and others. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare, and big science research.

Want to learn more about Bruker Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Bruker Corporation. The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips.

Bruker Corporation’s Stock Price as of Market Close

As of September 14, 2023, 4:00 PM CST, Bruker Corporation’s stock price was $67.45.

Bruker Corporation is up 4.64% from its previous closing price of $64.46.

During the last market session, Bruker Corporation’s stock traded between $61.26 and $64.83. Currently, there are 146.80 million shares of Bruker Corporation stock available for purchase.

Bruker Corporation’s price-earnings (P/E) ratio is currently at 29.9, which is high compared to the Advanced Medical Equipment & Technology industry median of 29.8. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Bruker Corporation Stock Price History

Bruker Corporation’s (BRKR) price is currently up 2.82% so far this month.

During the month of September, Bruker Corporation’s stock price has reached a high of $67.86 and a low of $61.02.

Over the last year, Bruker Corporation has hit prices as high as $84.84 and as low as $48.42. Year to date, Bruker Corporation’s stock is down 19.62%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Bruker Corporation Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 13, 2023, there were 10 analysts who downgraded Bruker Corporation’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Bruker Corporation’s financial health and valuation. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others.

Therefore, AAII developed a composite valuation to help resolve such issues. AAII’s Value Grade analyzes six distinct variables: price-to-sales (P/S) ratio, price-earnings (P/E) ratio, the ratio of enterprise value to earnings before interest, taxes, depreciation and amortization (EV/EBITDA), shareholder yield, price-to-book-value (P/B) ratio and price-to-free-cash-flow (P/FCF) ratio.

Bruker Corporation’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Bruker Corporation (BRKR) by visiting AAII Stock Evaluator.

Relative Price Strength of Bruker Corporation

Relative price strength addresses the relationship between a stock price’s trend and the price trend of the market. This ratio is expressed as a percentage and helps investors understand a company’s momentum as well as its value. You can use relative price strength to select investments that have been outperforming the market or a specific benchmark.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. The weighted four-quarter relative price strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40%, and each of the three previous quarters are given a weighting of 20%.

As of September 13, 2023, Bruker Corporation has a weighted four-quarter relative price strength of -1.92%, which translates to a Momentum Score of 61 and is considered to be Strong.

Want to learn more about how Bruker Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Bruker Corporation Stock Price: Bottom Line

As of September 14, 2023, Bruker Corporation’s stock price is $67.45, which is up 4.64% from its previous closing price.

At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and analytics before making a decision. Whether you decide it’s a good time to buy or sell Bruker Corporation’s stock based on its stock price forecast is ultimately up to you.

It’s important to understand that stock prices are driven by a variety of factors, but ultimately the price at any given moment is due to the supply and demand in the market. Stock price overviews, like the one you just read, only give you a small snapshot of a company’s performance, value and momentum.

By becoming an A+ Investor subscriber, you will have full access to analytics, grades, stock screens, commentary and more so you can invest with confidence.